MASTER THE NUMBERS (Biostatistics & Epidemiology)
- Description
- Curriculum
- Reviews
Biostatistics & Epidemiology Weekend Masterclass
Struggling with calculations in USMLE Step 1, Step 2 CK, or Step 3? This program is designed specifically for candidates who find the numerical and calculation-based aspects of the USMLE difficult.
Our intensive Friday-to-Sunday weekend program breaks down challenging biostatistics and epidemiology concepts into simple, understandable, step-by-step lessons. Through guided calculations, practical examples, and focused discussions, you will learn how to approach numerical questions with greater clarity, accuracy, and confidence.
From understanding formulas to interpreting data and solving exam-style problems, the goal is to help you move beyond memorization and develop the skills to tackle calculations effectively.
Program Highlights:
-
Simplified explanations of difficult concepts and formulas.
-
Step-by-step guidance through calculation-based questions.
-
Practical examples and USMLE-style questions.
-
Improved speed, accuracy, and confidence.
-
Focused weekend sessions running from Friday through Sunday.
Who Should Attend?
USMLE Step 1, Step 2 CK, and Step 3 candidates who struggle with biostatistics, epidemiology, and numerical problem-solving.
Stop avoiding the numbers. Start mastering them!
Join The Concept Academy and build the confidence to tackle biostatistics and epidemiology questions with a clearer strategy.
-
1BIOSTATISTICS AND EPIDEMIOLOGY 1Video lesson
Person-Time Estimates in Epidemiology
Festus led a discussion on epidemiology concepts, focusing on person-time estimates and their application in cohort studies. He explained that person-time estimates calculate the total time all participants in a study are at risk of developing a disease or outcome, and are used to calculate incident rates. Festus provided examples to illustrate how to calculate person-years for different study participants based on their time to event, loss to follow-up, or study completion.Person-Year Estimates Calculation Method
Festus explained the concept of person-year estimates and how to calculate incidence rates using a 2x2 table. He demonstrated the calculation method using an example with three study groups, showing how to determine the incidence rate by dividing the total number of new cases by the total person-years. The discussion was interrupted when students experienced technical difficulties with screen sharing, preventing some participants from seeing the shared content.2x2 Table for Medical Testing
FESTUS explained the structure and proper format of a 2x2 table used for calculating sensitivity and specificity in medical testing. He demonstrated how to identify true positives, true negatives, false positives, and false negatives, and clarified that sensitivity is used to evaluate a test's ability to correctly identify people with disease, while specificity assesses a test's ability to correctly identify people without disease. FESTUS emphasized that highly sensitive tests are useful for screening purposes when a test result is negative, while highly specific tests are better for diagnosis when a test result is positive.Medical Testing Metrics Concepts
Festus explained concepts related to sensitivity, specificity, predictive values, and the impact of prevalence and cutoff levels in medical testing. He demonstrated how these metrics are calculated and how they change with variations in test cutoffs, using examples like COVID-19 testing to illustrate the relationship between prevalence and predictive values. Festus emphasized understanding these concepts through correlation with a two-by-two table and arrows, rather than memorization, and provided guidance on how to approach related questions in exams.ROC Curves for Diagnostic Tests
Festus explained the concept of receiver operating characteristic (ROC) curves for comparing diagnostic tests, demonstrating how to interpret sensitivity and false positive rate on the graph. He showed how to identify the most accurate test by finding the curve closest to the optimal angle in the top left corner. Festus then walked through a practical example of calculating sensitivity and specificity from test results for a 28-year-old woman with chronic diarrhea, demonstrating the step-by-step calculations for two different test tables.Medical Diagnostic Test Concepts
Festus explained concepts related to medical diagnostic tests, focusing on sensitivity and specificity calculations for celiac sprue diagnosis using Test X and Test Y. He discussed how to determine which test should be used for screening based on their respective sensitivity and specificity values, concluding that Test Y should be preferred due to higher sensitivity and specificity. Festus also explained the difference between triple screening and amniocentesis in terms of their ability to detect cases of Down syndrome, clarifying that amniocentesis has a higher predictive value due to its higher sensitivity in detecting cases.Medical Statistics Educational Session
Festus conducted a detailed educational session on medical statistics concepts, focusing on likelihood ratios, study designs, and risk calculations. He explained how to calculate positive and negative likelihood ratios using sensitivity and specificity, provided examples of different study types including case series, cross-sectional studies, case-control studies, and cohort studies, and demonstrated how to interpret and calculate odds ratios and relative risks using 2x2 tables. The session included practical examples and calculations, with Festus encouraging participants to ask questions and continue the discussion in the next session where they would work through more examples. -
2BIOSTATISTICS AND EPIDEMIOLOGY 2Video lesson
Study Designs and Statistical Concepts
Festus continued his educational session on study designs and statistical concepts, building on previous topics about cohort studies and 2x2 tables. He explained prospective and retrospective study approaches, including how to properly structure 2x2 tables with disease and exposure variables, and demonstrated calculations for relative risk, absolute risk, attributable risk, and risk reduction measures using several practical examples. The session covered key statistical concepts including number needed to treat and harm, and concluded with explanations of twin concordance studies, adoption studies, ecological studies, and randomized controlled trials, including the structural components of RCTs such as randomization and its purpose of creating similar baseline characteristics between treatment and control groups.Randomized Control Trials Overview
Festus explained the key components of randomized control trials, including randomization to create similar baseline groups, control groups for comparison, and blinding to prevent measurement and observer bias. He detailed different types of blinding (simple, double, and triple) and described the parallel and crossover designs, highlighting advantages and disadvantages of each approach. The discussion included an example of how to determine if randomization was successful by checking baseline patient characteristics between groups.Factorial Design in Clinical Trials
Festus explained factorial design concepts, defining factors as independent variables and levels as different options within those variables. He demonstrated how to calculate the number of groups in factorial designs by multiplying the levels of each factor together, using examples with drugs A, B, and C. Festus then applied these concepts to a real clinical trial example about hyperkalemia treatment, showing how patients were randomized based on three factors: type of blood pressure medication (beta blocker, ACEI, or calcium channel blocker) and two blood pressure levels, resulting in six different groups. The discussion concluded with an explanation of different analysis methods including intention-to-treat analysis.Intention-to-Treat Analysis Explanation
Festus explained the concept of intention-to-treat analysis, comparing it to per-protocol and as-treated analyses using a hypothetical example with ibuprofen and paracetamol. He described how intention-to-treat analysis maintains the original group structure regardless of whether participants followed the protocol, reducing attrition bias and providing a more realistic assessment of treatment effectiveness in real-world conditions. Festus then introduced a question about a study design comparing tramadol and placebo for painful polyneuropathy, but the transcript ended before he completed explaining the answer options.Clinical Trial Protocol Adherence Discussion
FESTUS explained a clinical trial scenario involving 150 patients with multiple myeloma who were randomized to receive either a new drug or placebo. He discussed how nine patients taking the new drug and three patients taking placebo did not follow the protocol by taking one pill per day as instructed. The discussion focused on how to handle data from patients who did not adhere to the protocol, with FESTUS explaining the difference between intention-to-treat and per-protocol analyses. The meeting took a brief break after this discussion.Clinical Trials Phases Overview
Festus explained the different phases of clinical trials, focusing on phases 1-4 and their key objectives. He described phase 1 as checking safety in healthy volunteers, phase 2 as determining if the drug works in patients with the disease, phase 3 as comparing the new drug to existing treatments, and phase 4 as monitoring long-term adverse effects after the drug is approved. The group then practiced identifying which phase specific clinical trial examples belonged to, with Maureen and Abiola participating in the discussions and confirming their answers.Research Biases Educational Session
Festus conducted a detailed educational session on research biases, explaining various types of selection bias, measurement bias, observer bias, recall bias, confounding bias, and effect modification. He provided examples and practical scenarios to illustrate how these biases can affect research results, including specific case studies and questions for participants to understand key concepts like relative risk, stratification, and statistical significance. The session concluded with plans to cover statistical distributions and error types in the next meeting, with Festus emphasizing that the content covered would be relevant for upcoming exams. -
3BIOSTATISTICS AND EPIDEMIOLOGY 3Video lesson
Statistical Distributions and Measures
Festus conducted a PowerStart webinar on statistical distributions, focusing on measures of central tendency including mean, median, and mode. He explained that while exam questions won't require complex calculations, they will test understanding of how these measures are affected by outliers, with mean being most affected and mode being least affected. Festus demonstrated practical examples using sample data to show how to calculate these measures and apply them to medical scenarios, emphasizing that the key is understanding the concepts rather than performing complex calculations.Statistical Concepts and Analysis
FESTUS explained statistical concepts including mode, standard deviation, and standard error to help with understanding data analysis. He described how standard error is related to standard deviation and sample size, noting that increasing sample size reduces standard error. FESTUS also explained normal distribution and how to calculate probabilities using standard deviations, providing examples of how to apply these concepts to solve statistical problems.Statistical Concepts and Applications
Festus explained statistical concepts including normal distribution, standard deviations, and skewness to students. He demonstrated how to calculate and interpret values using examples of height and weight data, emphasizing the importance of understanding distribution types and measures of central tendency. Festus also covered hypothesis testing, explaining the concepts of null and alternative hypotheses, and introduced p-values as probabilities of observing differences due to chance.Statistical Concepts and Power Analysis
Festus explained the concepts of p-values, Type I and Type II errors, alpha levels, and statistical power in research. He described how p-values indicate the probability that an observed difference is due to chance, with small p-values suggesting significant results. Festus explained that Type I error (alpha) represents the probability of rejecting the null hypothesis when it is true, typically set at 5% for exams, while Type II error (beta) represents the probability of failing to reject the null hypothesis when it is false. He also discussed how statistical power, which is related to beta, affects a study's ability to detect differences, noting that increasing sample size, expected effect size, and measurement precision can enhance power.Statistical Significance and P-Values
Festus led a discussion on statistical concepts, focusing on p-values, alpha levels, and the interpretation of study results. He explained the importance of power and sample size in determining statistical significance, using examples to illustrate how p-values relate to alpha levels and the potential for Type I and Type II errors. The group discussed the difference between statistical and clinical significance, with Festus emphasizing the need to correlate p-values with alpha levels to correctly interpret study results.Statistical Significance Education Session
Festus conducted a detailed educational session on statistical significance and confidence intervals, explaining concepts like p-values, type I errors, and how sample size affects confidence intervals. The group practiced analyzing various study results to determine statistical significance, with participants working through examples including cocoa intake effects on blood pressure and surgical techniques for mandible fractures. Festus announced that similar sessions would continue biweekly, focusing on Step 1 preparation rather than Step 2 or 3, with participants encouraged to practice with question banks between sessions. -
4BIOSTATISTICS AND EPIDEMIOLOGY 4Video lesson
Epidemiology and Biostatistics Teaching Session
Festus conducted a teaching session on epidemiology and biostatistics concepts for the USMLE exam, focusing on person-time estimates and incidence rates. He explained how to calculate person-years contributed by study participants and demonstrated the use of 2x2 tables for sensitivity and specificity calculations. The session was interrupted when Festus needed to attend to an emergency, with students agreeing to a 10-minute break.Medical Testing Sensitivity and Specificity
Festus explained the concepts of sensitivity and specificity in medical testing, using analogies to help students understand how these measures work. He demonstrated how to use a two-by-two table and arrow diagrams to calculate positive and negative predictive values, emphasizing that these values are affected by prevalence. Festus illustrated these concepts with real-world examples, particularly using COVID-19 to show how predictive values change with varying disease prevalence in a community.Diagnostic Test Evaluation Methods
Festus explained how to apply positive predictive value and negative predictive value in exams, emphasizing the importance of understanding how cutoff values affect sensitivity, specificity, and these predictive values. He demonstrated how to interpret receiver operating characteristic (ROC) curves and select the best diagnostic test based on the curve's position closest to the top-left corner. Festus also walked through an example question about comparing two tests for celiac sprue, showing how to calculate and compare their sensitivity and specificity to determine which test is better for screening and diagnosis.Medical Statistics Teaching Session
Festus led a teaching session on medical statistics, focusing on sensitivity, specificity, and likelihood ratios. He explained how to calculate positive and negative predictive values using a step-by-step approach with example questions. The session included detailed explanations of likelihood ratios, including how to interpret results and convert pre-test to post-test probabilities. Festus provided practical examples and formulas for calculating these statistical measures, emphasizing the importance of understanding the concepts for medical decision-making.Observational Studies Types and Methods
Festus explained different types of observational studies, including case series, cross-sectional studies, and case-control studies. He emphasized that case series are purely descriptive with no control groups, cross-sectional studies measure prevalence at a specific point in time, and case-control studies compare groups with and without a disease to investigate potential causes. Festus also discussed the importance of understanding recall bias as a potential issue in case-control studies and explained how to calculate odds ratios using 2x2 tables.Study Design Comparison and Calculations
Festus explained the differences between various study designs, particularly focusing on case control studies, cohort studies, and their applications. He clarified that case control studies are retrospective and useful for rare conditions, while cohort studies can be prospective or retrospective and are better for studying exposure and outcomes over time. Festus also explained how to calculate measures like relative risk, absolute risk reduction, and attributable risk using 2x2 tables, emphasizing that students should understand the concepts rather than memorizing specific formulas.Interpreting Medical Research Statistics
Festus taught a lesson on interpreting medical research statistics, explaining the difference between relative risk reduction and absolute risk reduction. He used examples of a 73-year-old woman with osteoporosis and a study on heparin solutions to demonstrate how pharmaceutical companies often quote relative risk reductions that seem larger than the actual absolute risk differences. The class also learned about number needed to treat calculations and different study designs including concordance studies, adoption studies, and ecological studies, with Festus warning about ecological fallacy in applying population-level data to individuals.Ecological Fallacy and RCT Concepts
Festus explained the concept of ecological fallacy using an example of doctors in America and discussed the importance of randomization in randomized controlled trials (RCTs). He detailed how randomization helps create two groups with similar baseline characteristics to reduce confounding and selection bias. Festus also covered the components of RCTs, including the use of control groups (placebo, active control, or no treatment control), blinding (single, double, or triple), and prospective follow-up, emphasizing the role of double blinding in balancing the placebo effect and reducing observer bias.Randomized Control Trials Design Types
Festus explained different types of randomized control trials, including parallel design where participants receive only one intervention throughout the study, crossover design where participants receive multiple interventions sequentially with a washout period, and factorial design which involves multiple interventions simultaneously. He discussed the advantages and disadvantages of each design, including crossover design's requirement for smaller sample sizes but longer study duration, and explained the concept of washout periods and their potential complications. Festus also covered analysis methods including intention-to-treat analysis which maintains the original randomization groups regardless of participant withdrawals or changes.Clinical Trial Analysis Methods
Festus taught a lesson on clinical trial analysis methods and phases, focusing on intention-to-treat, per-protocol, and as-treated analyses. He explained how intention-to-treat maintains randomization by keeping patients in their original groups even if they didn't fully adhere to the protocol, while per-protocol analysis excludes non-compliant participants. Festus also covered the four main phases of clinical trials (Phase 1-4), explaining that Phase 1 focuses on safety, Phase 2 on efficacy, Phase 3 on effectiveness through comparison, and Phase 4 on long-term adverse effects after market approval. The session concluded with practice questions about identifying which phase a clinical trial belongs to, and Festus announced that the next session would cover off-label drug use. -
5BIOSTATISTICS AND EPIDEMIOLOGY 5Video lesson
Hypothesis Testing Concepts Overview
Festus continued a statistics lesson on hypothesis testing, explaining the concepts of null and alternative hypotheses, p-values, and their interpretations. He described how p-values indicate the probability that observed differences or associations are due to chance, with small p-values suggesting the results are likely not due to chance and would likely be reproducible by other researchers. Festus explained that researchers aim for p-values less than alpha (the error rate in the null hypothesis) to determine statistical significance, with results being considered statistically significant when p < alpha and not significant when p > alpha.Type 1 and Type 2 Errors
Festus and Omoseye discussed the concepts of type 1 and type 2 errors in statistical analysis using a two-by-two table to illustrate true positives, true negatives, false positives, and false negatives. They emphasized the importance of focusing on the null hypothesis rather than alternatives and explained how to identify errors by comparing reality with study findings. Festus simplified the understanding of type 1 error as rejecting the null hypothesis when it should be accepted and introduced the concept of alpha (set at 5% for exams) as the acceptable error rate in research.Statistical Power Concepts Discussion
Festus discussed the concepts of type I and type II errors in statistical research, explaining how they relate to confidence levels and power respectively. He illustrated that power is necessary to overcome the null hypothesis and reveal differences or associations in research findings. Festus also drew parallels between statistical power and personal life, emphasizing the importance of seeking power through prayer and collaboration to overcome obstacles and achieve desired outcomes.Statistical Power in Research
Festus taught the class about statistical power in research, explaining that increasing sample size is the best way to increase power and the importance of collaboration with others. He used an example of blood cholesterol levels to demonstrate how to calculate power (1 - beta), showing that a 20% beta probability corresponds to an 80% power level. The class discussed a clinical scenario about testing drug B versus standard care for acute ST elevation, but the transcript ended before the specific question about maximizing power in that study could be fully addressed.Statistical Power in Research Studies
Festus discussed the importance of statistical power in research, using examples to illustrate how sample size affects study results. He explained the concept of meta-analysis, which combines results from multiple studies to increase statistical power and provide more reliable conclusions. Festus also presented a case study about a clinical trial testing a new cream for atopic dermatitis, highlighting how a lack of statistical significance could be due to insufficient sample size.Statistical vs Clinical Significance Concepts
Festus explained the concepts of statistical versus clinical significance, emphasizing that while statistical significance focuses on p-values and power, clinical significance considers the impact on patient treatment outcomes. He discussed the difference between estimates (related to samples) and parameters (related to populations), and explained how to calculate confidence intervals using the formula: mean ± (z-value * standard error). Festus also covered hypothesis testing for mean differences, noting that for difference tests, the confidence interval must not contain zero, while for relative risk, it must not contain 1.0 to be statistically significant.Statistical Concepts and Methods Discussion
Festus led a discussion on statistical concepts, focusing on p-values, confidence intervals, and meta-analysis. The group analyzed a study on cocoa intake and systolic blood pressure, identifying which studies were statistically significant and discussing the overall effect size. Festus explained the concept of meta-analysis, including forest plots and how to interpret them, and outlined common statistical tests for numerical and categorical variables. The session concluded with an overview of t-tests, analysis of variance (ANOVA), and chi-square tests for different types of data analysis.Statistical Tests and Correlation Analysis
Festus explained the difference between Fisher's exact test and Chi-square test, noting that Fisher's test is used for small sample sizes while Chi-square is used for larger samples with categorical variables. He then discussed correlation analysis, explaining how to interpret correlation coefficients (R) and their direction (positive or negative) to determine the strength and direction of linear relationships between two quantitative variables. Festus provided examples to illustrate these concepts, including how to interpret correlation values like 0.85 and -0.72.Statistics Lesson on Correlation and Causality
Festus taught a statistics lesson covering correlation, causality, and regression analysis, explaining the differences between these statistical methods and when to use each one. He emphasized that correlation only shows relationship between variables while regression can demonstrate causality, and he provided examples using biostatistics scores and lecture hours. The class discussed upcoming topics with Dr. Precious likely to teach the next session, and they decided to cover musculoskeletal before neurology topics. Festus encouraged students to seriously practice the concepts and review videos to improve their understanding.
Popular Courses
Archive
Working hours
| Monday | 9:30 am - 6.00 pm |
| Tuesday | 9:30 am - 6.00 pm |
| Wednesday | 9:30 am - 6.00 pm |
| Thursday | 9:30 am - 6.00 pm |
| Friday | 9:30 am - 5.00 pm |
| Saturday | Closed |
| Sunday | Closed |